Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 0: clinchem.2007.096784v1, 2008; 10.1373/clinchem.2007.096784
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.096784v1
54/3/567    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brady, J.
Right arrow Articles by Orning, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brady, J.
Right arrow Articles by Orning, L.

Received on September 4, 2007
Accepted on December 5, 2007

Hematology

Active B12: A Rapid, Automated Assay for Holotranscobalamin on the Abbott AxSYM Analyzer

Jeff Brady 1, Lesley Wilson 1, Lynda McGregor 1, Edward Valente 1, Lars Orning 2*

1 Axis-Shield Diagnostics, Ltd., Dundee, Scotland, UK
2 Axis-Shield POC, Oslo, Norway

* To whom correspondence should be addressed. E-mail: lars.orning{at}no.axis-shield.com.

BACKGROUND: Conventional tests for vitamin B12 deficiency measure total serum vitamin B12, whereas only that portion of vitamin B12 carried by transcobalamin (holotranscobalamin) is metabolically active. Measurement of holotranscobalamin (holoTC) may be more diagnostically accurate for detecting B12 deficiency that requires therapy. We developed an automated assay for holoTC that can be used on the Abbott AxSYM immunoassay analyzer.

METHODS: AxSYM Active B12 is a 2-step sandwich microparticle enzyme immunoassay. In step 1, a holoTC-specific antibody immobilized onto latex microparticles captures holoTC in samples of serum or plasma. In step 2, the captured holoTC is detected with a conjugate of alkaline phosphatase and antiTC antibody.

RESULTS: Neither apoTC nor haptocorrin exhibited detectable cross-reactivity. The detection limit was ≤0.1 pmol/L. Within-run and total imprecision (CV ranges) were 3.4%–5.1% and 6.3%–8.5%, respectively. Assay CVs were <20% from at least 3 pmol/L to 107 pmol/L. With diluted serum samples, measured concentrations were 104%–114% of the expected values in the working range of the assay. No interference from bilirubin, hemoglobin, triglycerides, erythrocytes, rheumatoid factor, or total protein was detected at expected (abnormal) concentrations. A comparison of the AxSYM Active B12 assay with a commercial RIA for holoTC yielded the regression equation: AxSYM = 0.98RIA + 4.7 pmol/L (Syx, 11.4 pmol/L; n = 204). Assay throughput was 45 tests/h. A 95% reference interval of 19–134 pmol/L holoTC was established with samples from 292 healthy individuals.

CONCLUSIONS: The AxSYM Active B12 assay allows rapid, precise, sensitive, specific, and automated measurement of human holoTC in serum and plasma.


The following articles in journals at HighWire Press have cited this article:


Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. K. Lee, H.-S. Kim, and H. J. Kang
Holotranscobalamin as an Indicator of Vitamin B12 Deficiency in Gastrectomized Patients
Ann. Clin. Lab. Sci., January 1, 2009; 39(4): 361 - 366.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.